Piperidine → HCID 59375150, compound
Reaction equation
[F:1][C:2]1[CH:35]=[CH:34][C:5]([C:6]([NH:8][C:9]2[C:10]([CH3:33])=[C:11]([C:15]3[C:27]4[C:26]5[C:21](=[CH:22][C:23]([CH:28]=O)=[CH:24][CH:25]=5)[NH:20][C:19]=4[C:18]([C:30]([NH2:32])=[O:31])=[CH:17][CH:16]=3)[CH:12]=[CH:13][CH:14]=2)=[O:7])=[CH:4][CH:3]=1.[NH:36]1[CH2:41][CH2:40][CH2:39][CH2:38][CH2:37]1.C(O[BH-](OC(=O)C)OC(=O)C)(=O)C.[Na+]>C1COCC1.O>[F:1][C:2]1[CH:3]=[CH:4][C:5]([C:6]([NH:8][C:9]2[C:10]([CH3:33])=[C:11]([C:15]3[C:27]4[C:26]5[C:21](=[CH:22][C:23]([CH2:28][N:36]6[CH2:41][CH2:40][CH2:39][CH2:38][CH2:37]6)=[CH:24][CH:25]=5)[NH:20][C:19]=4[C:18]([C:30]([NH2:32])=[O:31])=[CH:17][CH:16]=3)[CH:12]=[CH:13][CH:14]=2)=[O:7])=[CH:34][CH:35]=1Participants
Reactant 3
Product 1
Reagents, catalysts & solvents 2
Procedure
Step 2 A suspension of 4-(3-(4-fluorobenzamido)-2-methylphenyl)-7-formyl-9H-carbazole-1-carboxamide (30 mg, 0.064 mmol) in THF (3 mL) was treated with piperidine (16.46 mg, 0.193 mmol) and sodium triacetoxyborohydride (34.1 mg, 0.161 mmol). The mixture was stirred at rt for 3.5 h, the was treated again with additional piperidine (16.5 mg, 0.193 mmol) and sodium triacetoxyborohydride (20 mg). After stirring overnight, the mixture was diluted with water and extracted with EtOAc. The organic phase was washed with brine, dried and concentrated. The residue was purified by preparative HPLC to provide 4-(3-(4-fluorobenzamido)-2-methylphenyl)-7-(piperidin-1-ylmethyl)-9H-carbazole-1-carboxamide (14 mg, 39%). 1H NMR (400 MHz, methanol-d4) δ 8.06 (2H, dd, J=8.7, 5.4 Hz), 7.98 (1H, d, J=7.8 Hz), 7.63 (1H, s), 7.52 (1H, d, J=7.3 Hz), 7.44 (1H, t, J=7.8 Hz), 7.18-7.31 (3H, m), 7.07 (2H, d, J=7.5 Hz), 6.96-7.02 (1H, m), 3.96 (2H, s), 2.72-2.88 (4H, m), 1.99 (3H, s), 1.63-1.75 (4H, m), 1.48-1.60 (2H, m). Mass spectrum m/z 535.2 (M+H)+.
Workup
- stirringAfter stirring overnight
- extractionextracted with EtOAc
- washThe organic phase was washed with brine
- customdried
- concentrationconcentrated
- customThe residue was purified by preparative HPLC
Sources & evidence
- ORD record
- ord-720128ce85604e8994d96de574cb8d65
- Source dataset
- uspto-grants-2011_12
- Patent number
- US08084620B2
Reaction notes
Loading…